王平原 Prof. Pingyuan WANG

发布时间:2021-09-29浏览次数:806

王平原   博士,教授,博士生导师

中国海洋大学“青年英才工程”第一层次特聘教授

Emailwang-jimmy2010@hotmail.com

Tel: 15192525078


科研领域:

基于海洋天然产物的药物先导物发现


主要研究方向及成果

以神经系统疾病、肿瘤和炎症等人类重大疾病为导向,运用基于天然产物和老药新用的新型小分子药物发现策略,围绕钠通道、GPCR cAMP 信号转导通路为靶标,进行分子靶向的药物先导化合物发现及其作用机制研究。发表J. Med. Chem.Euro. J. Med. Chem.Org. Lett.SCI论文20余篇,其中第一作者(含共一)SCI文章12篇;申请专利8项,授权2项;获得美国德克萨斯大学颁发的Herin转化研究奖“Herin Translational Research Award”;受邀多次为CancersCells等杂志审稿人。


Dr. Pingyuan Wang

Education:

B.Sc.Chemistry, Central China Normal University (2006-2010)

Ph. D.Medicinal Chemistry and Pesticide science, Central China Normal University and Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2010-2016)


Work Experience:

PostdocDepartment of Pharmacology & Toxicology, University of Texas Medical Branch (2016.06-2021.06)

ProfessorInstitute of Evolution & Marine Biodiversity, Ocean University of China (2020.9- )


Research Interests:

Design, synthesis and biological evaluations of small molecules as chemical probes for probing function or pharmacological tools for cancer, inflammations, CNS disorders and other human diseases.


代表著作:


1.P. Wang, D. van der Hoeven, N. Ye, H. Chen, Z. Liu, X. Ma, D. Montufar-Solis, K. M. Rehl, K. Cho, S. Thapa, W. Chen, R. van der Hoeven, J. A. Frost, J. F. Hancock, J. Zhou. Scaffold repurposing of fendiline: identification of potent KRAS plasma membrane localization inhibitors. Eur. J. Med. Chem. 2021, 217, 113381.

2.P. Wang, D. E. Felsing, H. Chen, S. J. Stutz, R. E. Murphy, K. A. Cunningham, J. A. Allen, J. Zhou. Discovery of Potent and Brain Penetrant GPR52 Agonists that Suppress Psychostimulant Behavior. J. Med. Chem. 2020, 63, 13951-13972.

3.P. Wang, P.A. Wadsworth, N. M. Dvorak, A. K. Singh, H. Chen, Z. Liu, R. Zhou, L. M. F. Holthauzen, J. Zhou, F. Laezza. Design, Synthesis, and Pharmacological Evaluation of Analogs Derived from the PLEV Tetrapeptide as Protein-Protein Interaction Modulators of Voltage-Gated Sodium Channel 1.6. J. Med. Chem. 2020, 63, 11522-11547.

4.P. Wang, U. Luchowska-Stańska, B. V. Basten, H. Chen, Z. Liu, J. Wiejak, P. Whelan, D. Morgan, E. Lochhead, G. Barker, H. R., S. J. Yarwood, J. Zhou. Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators.J. Med. Chem. 2020, 63, 5159-5184.

5.P. Wang, D. E. Felsing, H. Chen, S. R. Raval, J. A. Allen, J. Zhou. Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists. ACS Med. Chem. Lett. 2019, 10, 792-799.

6.Y. Wang,# P. Wang,# Y. Wang, G. Yang, A. Zhang, Z. Miao. An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy. J. Med. Chem. 2016, 59, 9575-9598.

7.P. Wang, S. Song, Z. Miao, G. Yang, A. Zhang. InBr3-Mediated One-Pot Synthesis of 2-(Polyhydroxylatedalkyl)-N-aryl-/-alkylpyrroles from 1,2-Cyclopropa-3-pyranone and Amines. Org. Lett. 2013, 15, 3852-3855.